{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:10:09Z","timestamp":1758845409501,"version":"3.44.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.jaci.2012.01.050","type":"journal-article","created":{"date-parts":[[2012,2,2]],"date-time":"2012-02-02T13:35:32Z","timestamp":1328189732000},"page":"646-652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Advances in upper airway diseases and allergen immunotherapy in 2011"],"prefix":"10.1016","volume":"129","author":[{"given":"Joy","family":"Hsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol A.","family":"Saltoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro C.","family":"Avila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2012.01.050_bib1","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.jaci.2011.05.039","article-title":"Early-life risk factors and incidence of rhinitis: results from the European Community Respiratory Health Study\u2014an international population-based cohort study","volume":"128","author":"Matheson","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib2","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.jaci.2011.02.023","article-title":"Gestational age at birth and risk of allergic rhinitis in young adulthood","volume":"127","author":"Crump","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib3","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jaci.2011.08.035","article-title":"Polyinosinic:polycytidylic acid induces protein kinase D-dependent disassembly of apical junctions and barrier dysfunction in airway epithelial cells","volume":"128","author":"Rezaee","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib4","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.jaci.2011.06.012","article-title":"Nasal allergen provocation test with multiple aeroallergens detects polysensitization in local allergic rhinitis","volume":"128","author":"Rondon","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib5","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jaci.2011.05.013","article-title":"The effects of an anti-IL-13 mAb on cytokine levels and nasal symptoms following nasal allergen challenge","volume":"128","author":"Nicholson","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib6","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.jaci.2011.02.045","article-title":"Petasol butenoate complex (Ze 339) relieves allergic rhinitis-induced nasal obstruction more effectively than desloratadine","volume":"127","author":"Dumitru","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib7","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jaci.2011.01.037","article-title":"Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis","volume":"127","author":"Baroody","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib8","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jaci.2011.09.001","article-title":"Inflammation-mediated upregulation of centrosomal protein 110, a negative modulator of ciliogenesis, in patients with chronic rhinosinusitis","volume":"128","author":"Lai","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib9","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jaci.2010.12.011","article-title":"Role of p63\/p73 in epithelial remodeling and their response to steroid treatment in nasal polyposis","volume":"127","author":"Li","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jaci.2011.03.017","article-title":"Increased expression of the chemokine CCL23 in eosinophilic chronic rhinosinusitis with nasal polyps","volume":"128","author":"Poposki","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib11","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.jaci.2011.08.037","article-title":"Evidence for intranasal antinuclear autoantibodies in patients with chronic rhinosinusitis with nasal polyps","volume":"128","author":"Tan","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib12","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jaci.2011.07.056","article-title":"Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis","volume":"128","author":"Gevaert","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib13","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jaci.2011.04.045","article-title":"Efficacy and tolerability of systemic methylprednisolone in children and adolescents with chronic rhinosinusitis: a double-blind, placebo-controlled randomized trial","volume":"128","author":"Ozturk","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib14","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.4049\/jimmunol.1000833","article-title":"Conjunctival goblet cell secretion stimulated by leukotrienes is reduced by resolvins D1 and E1 to promote resolution of inflammation","volume":"186","author":"Dartt","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib15","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ajo.2010.10.001","article-title":"Pre-seasonal treatment with topical olopatadine suppresses the clinical symptoms of seasonal allergic conjunctivitis","volume":"151","author":"Shimura","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jaci.2012.01.050_bib16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaci.2011.01.065","article-title":"Reduced expression of COXs and production of prostaglandin E(2) in patients with nasal polyps with or without aspirin-intolerant asthma","volume":"128","author":"Roca-Ferrer","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib17","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jaci.2011.07.037","article-title":"Early-life risk factors and allergic rhinitis: comparing European and US data","volume":"128","author":"Ramsey","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib18","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.jaci.2011.01.017","article-title":"Vitamin D levels and food and environmental allergies in the United States: results from the National Health and Nutrition Examination Survey 2005-2006","volume":"127","author":"Sharief","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib19","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jaci.2011.07.015","article-title":"Cord blood 25-hydroxyvitamin D levels are associated with aeroallergen sensitization in children from Tucson, Arizona","volume":"128","author":"Rothers","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib20","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jaci.2011.08.030","article-title":"A genome-wide meta-analysis of genetic variants associated with allergic rhinitis and grass sensitization and their interaction with birth order","volume":"128","author":"Ramasamy","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib21","doi-asserted-by":"crossref","first-page":"13445","DOI":"10.1073\/pnas.0901944106","article-title":"GARP (LRRC32) is essential for the surface expression of latent TGF-beta on platelets and activated FOXP3+ regulatory T cells","volume":"106","author":"Tran","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2012.01.050_bib22","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0140-6736(11)60874-X","article-title":"Identification of IL6R and chromosome 11q13.5 as risk loci for asthma","volume":"378","author":"Ferreira","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2012.01.050_bib23","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jaci.2007.01.006","article-title":"Local IgE production and positive nasal provocation test in patients with persistent nonallergic rhinitis","volume":"119","author":"Rondon","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib24","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1056\/NEJMoa1106469","article-title":"Lebrikizumab treatment in adults with asthma","volume":"365","author":"Corren","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2012.01.050_bib25","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/archotol.130.12.1381","article-title":"Butterbur Ze339 for the treatment of intermittent allergic rhinitis: dose-dependent efficacy in a prospective, randomized, double-blind, placebo-controlled study","volume":"130","author":"Schapowal","year":"2004","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaci.2012.01.050_bib26","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/ptr.1705","article-title":"Treating intermittent allergic rhinitis: a prospective, randomized, placebo and antihistamine-controlled study of Butterbur extract Ze 339","volume":"19","author":"Schapowal","year":"2005","journal-title":"Phytother Res"},{"key":"10.1016\/j.jaci.2012.01.050_bib27","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jaci.2010.10.058","article-title":"How representative are clinical study patients with allergic rhinitis in primary care?","volume":"127","author":"Costa","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.devcel.2008.07.004","article-title":"CP110 suppresses primary cilia formation through its interaction with CEP290, a protein deficient in human ciliary disease","volume":"15","author":"Tsang","year":"2008","journal-title":"Dev Cell"},{"key":"10.1016\/j.jaci.2012.01.050_bib29","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jaci.2008.03.002","article-title":"Evidence of a role for B cell-activating factor of the TNF family in the pathogenesis of chronic rhinosinusitis with nasal polyps","volume":"121","author":"Kato","year":"2008","journal-title":"J Allergy Clin Immunol"},{"issue":"20","key":"10.1016\/j.jaci.2012.01.050_bib30","first-page":"1","article-title":"European position paper on rhinosinusitis and nasal polyps 2007","author":"Fokkens","year":"2007","journal-title":"Rhinol Suppl"},{"key":"10.1016\/j.jaci.2012.01.050_bib31","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0091-6749(97)80019-X","article-title":"IL-5 synthesis is upregulated in human nasal polyp tissue","volume":"99","author":"Bachert","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib32","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jaci.2010.10.038","article-title":"Chronic cough and irritable larynx","volume":"127","author":"Bucca","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib33","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jaci.2011.08.004","article-title":"Chronic rhinosinusitis: epidemiology and medical management","volume":"128","author":"Hamilos","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib34","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jaci.2011.05.022","article-title":"Genetics and phenotyping in chronic sinusitis","volume":"128","author":"Payne","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib35","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jaci.2011.07.049","article-title":"Pathogenesis of chronic rhinosinusitis: inflammation","volume":"128","author":"Van Crombruggen","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib36","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4065\/mcp.2010.0392","article-title":"Rhinosinusitis diagnosis and management for the clinician: a synopsis of recent consensus guidelines","volume":"86","author":"Meltzer","year":"2011","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"10.1016\/j.jaci.2012.01.050_bib37","first-page":"CD008263","article-title":"Topical and systemic antifungal therapy for the symptomatic treatment of chronic rhinosinusitis","author":"Sacks","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.jaci.2012.01.050_bib38","first-page":"CD009274","article-title":"Topical steroid for chronic rhinosinusitis without polyps","author":"Snidvongs","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaci.2012.01.050_bib39","first-page":"CD008115","article-title":"Systemic corticosteroids for acute sinusitis","volume":"12","author":"Venekamp","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaci.2012.01.050_bib40","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/ni.1627","article-title":"Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation","volume":"9","author":"Haworth","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib41","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.plefa.2008.09.012","article-title":"Systems approach with inflammatory exudates uncovers novel anti-inflammatory and pro-resolving mediators","volume":"79","author":"Serhan","year":"2008","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.jaci.2012.01.050_bib42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jaci.2010.11.032","article-title":"One hundred years of allergen immunotherapy: time to ring the changes","volume":"127","author":"Durham","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib43","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jaci.2010.10.034","article-title":"Future forms of immunotherapy","volume":"127","author":"Casale","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib44","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jaci.2010.11.030","article-title":"Mechanisms of allergen-specific immunotherapy","volume":"127","author":"Akdis","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib45","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jaci.2010.08.024","article-title":"Allergen-specific immunotherapy for respiratory allergies: from meta-analysis to registration and beyond","volume":"127","author":"Calderon","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib46","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jaci.2010.09.033","article-title":"Health economics of allergen-specific immunotherapy in the United States","volume":"127","author":"Lockey","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib47","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jaci.2010.09.037","article-title":"Disease-modifying effect and economic implications of sublingual immunotherapy","volume":"127","author":"Canonica","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib48","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaci.2010.10.014","article-title":"Patient characteristics associated with allergen immunotherapy initiation and adherence","volume":"127","author":"Hankin","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"suppl","key":"10.1016\/j.jaci.2012.01.050_bib49","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2010.09.034","article-title":"Allergen immunotherapy: a practice parameter third update","volume":"127","author":"Cox","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib50","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.jaci.2006.07.054","article-title":"Does allergen-specific immunotherapy represent a therapeutic option for patients with atopic dermatitis?","volume":"118","author":"Bussmann","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib51","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1398-9995.2006.00974.x","article-title":"Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study","volume":"61","author":"Werfel","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2012.01.050_bib52","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/j.1365-2222.2007.02783.x","article-title":"Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study","volume":"37","author":"Bussmann","year":"2007","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2012.01.050_bib53","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jaci.2009.03.017","article-title":"Venom immunotherapy reduces large local reactions to insect stings","volume":"123","author":"Golden","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib54","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jaci.2010.04.025","article-title":"Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: the importance of baseline serum tryptase","volume":"126","author":"Rueff","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib55","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S1081-1206(10)63556-9","article-title":"Effect of pretreatment with fexofenadine on the safety of immunotherapy in patients with allergic rhinitis","volume":"96","author":"Ohashi","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib56","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jaci.2010.12.1080","article-title":"Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies","volume":"127","author":"James","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib57","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jaci.2010.11.025","article-title":"Wasp venom immunotherapy induces activation and homing of CD4(+)CD25(+) forkhead box protein 3-positive regulatory T cells controlling T(H)1 responses","volume":"127","author":"Kerstan","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib58","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jaci.2010.12.003","article-title":"Impact of immunotherapy on blood dendritic cells in patients with Hymenoptera venom allergy","volume":"127","author":"Dreschler","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib59","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jaci.2010.07.031","article-title":"Honeybee venom immunotherapy in children using a 50-mug maintenance dose","volume":"127","author":"Houliston","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib60","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0091-6749(98)70167-8","article-title":"Long-term protection after stopping venom immunotherapy: results of re-stings in 200 patients","volume":"101","author":"Lerch","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib61","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/0091-6749(91)90392-2","article-title":"Honeybee venom allergy: results of a sting challenge 1 year after stopping successful venom immunotherapy in 86 patients","volume":"87","author":"Muller","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib62","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jaci.2010.10.025","article-title":"Three years of specific immunotherapy may be sufficient in house dust mite respiratory allergy","volume":"127","author":"Tabar","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib63","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jaci.2010.11.036","article-title":"Efficacy and safety of immunotherapy for allergies to Alternaria alternata in children","volume":"127","author":"Kuna","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib64","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.jaci.2010.12.013","article-title":"Local allergic rhinitis: allergen tolerance and immunologic changes after preseasonal immunotherapy with grass pollen","volume":"127","author":"Rondon","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib65","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jaci.2010.08.021","article-title":"Effect of birch pollen-specific immunotherapy on birch pollen-related hazelnut allergy","volume":"127","author":"van Hoffen","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib66","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaci.2011.03.049","article-title":"Subcutaneous immunotherapy and pharmacotherapy in seasonal allergic rhinitis: a comparison based on meta-analyses","volume":"128","author":"Matricardi","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib67","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jaci.2010.11.034","article-title":"Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescents","volume":"127","author":"Blaiss","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib68","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jaci.2010.11.035","article-title":"Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adults","volume":"127","author":"Nelson","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"suppl\u00a095","key":"10.1016\/j.jaci.2012.01.050_bib69","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1398-9995.2011.02639.x","article-title":"Sustained effects of grass pollen AIT","volume":"66","author":"Durham","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2012.01.050_bib70","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jaci.2011.06.022","article-title":"Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis","volume":"128","author":"Didier","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib71","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.jaci.2010.11.045","article-title":"House dust mite sublingual immunotherapy: results of a US trial","volume":"127","author":"Bush","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib72","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.anai.2011.03.012","article-title":"Efficacy of sublingual immunotherapy with house dust mite extract in polyallergen sensitized patients with allergic rhinitis","volume":"107","author":"Lee","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib73","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jaci.2010.09.017","article-title":"The Consolidated Standards of Reporting Trials (CONSORT) Statement applied to allergen-specific immunotherapy with inhalant allergens: a Global Allergy and Asthma European Network (GA(2)LEN) article","volume":"127","author":"Bousquet","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib74","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1365-2222.2011.03835.x","article-title":"Sublingual immunotherapy for allergic conjunctivitis: Cochrane systematic review and meta-analysis","volume":"41","author":"Calderon","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2012.01.050_bib75","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jaci.2011.04.033","article-title":"A novel approach in allergen-specific immunotherapy: Combination of sublingual and subcutaneous routes","volume":"128","author":"Keles","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib76","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jaci.2010.09.014","article-title":"Single-tree nut immunotherapy attenuates allergic reactions in mice with hypersensitivity to multiple tree nuts","volume":"127","author":"Kulis","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib77","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jaci.2010.11.029","article-title":"Development and preliminary clinical evaluation of a peptide immunotherapy vaccine for cat allergy","volume":"127","author":"Worm","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.01.050_bib78","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jaci.2011.03.011","article-title":"Carrier-bound, nonallergenic Ole e 1 peptides for vaccination against olive pollen allergy","volume":"128","author":"Twaroch","year":"2011","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009167491200173X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009167491200173X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:32:15Z","timestamp":1758789135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009167491200173X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":78,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S009167491200173X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2012.01.050","relation":{},"ISSN":["0091-6749"],"issn-type":[{"type":"print","value":"0091-6749"}],"subject":[],"published":{"date-parts":[[2012,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in upper airway diseases and allergen immunotherapy in 2011","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2012.01.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}